Related references
Note: Only part of the references are listed.Resting heart rate in cardiovascular disease
Kim Fox et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Modulation of rate by autonomic agonists in SAN cells involves changes in diastolic depolarization and the pacemaker current
Annalisa Bucchi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Optimal medical therapy with or without PCI for stable coronary disease
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris - A 3-month randomised, double-blind, multicentre, noninferiority trial
Witold Ruzyllo et al.
DRUGS (2007)
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction
GH Gislason et al.
EUROPEAN HEART JOURNAL (2006)
Funny channels in the control of cardiac rhythm and mode of action of selective blockers
Dario DiFrancesco
PHARMACOLOGICAL RESEARCH (2006)
Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels
A Bucchi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise
R Joannides et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Favourable long term prognosis in stable angina pectoris:: an extended follow up of the angina prognosis study in Stockholm (APSIS)
P Hjemdahl et al.
HEART (2006)
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
SC Smith et al.
CIRCULATION (2006)
Guidelines on the management of stable angina pectoris: executive summary
Kim Fox et al.
EUROPEAN HEART JOURNAL (2006)
Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina
JC Tardif et al.
EUROPEAN HEART JOURNAL (2005)
Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease - A meta-analysis
DG Katritsis et al.
CIRCULATION (2005)
The initial management of stable angina in Europe, from the Euro Heart Survey - A description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina
CA Daly et al.
EUROPEAN HEART JOURNAL (2005)
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina - A randomized controlled trial
BR Chaitman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina -: A randomized, double-blind, multicentered, placebo-controlled trial
JS Borer et al.
CIRCULATION (2003)
A single intravenous dose of ivabradine, a novel I-f inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction
M Manz et al.
CARDIOLOGY (2003)
Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis
WW Klein et al.
CORONARY ARTERY DISEASE (2002)
Share Paper
